Xofigo for Prostate Cancer

The Food and Drug Administration has very recently approved a new pharmaceutical, Xofigo, for the treatment of late stage prostate cancer. The drug is a new hope for the treatment of a kind of cancer that affects more than 50% of men over 55 and over 90% of men over 75 years of age. It [...]